Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cancer drug trial seeks to boost immune system against tumors

NCT ID NCT05856981

Summary

This early-stage trial is testing a new immunotherapy drug called ADU-1805, both alone and combined with an existing cancer drug (pembrolizumab), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to determine safe dosage levels and see how the body processes the drug. Researchers will enroll 130 participants with specific cancers including colorectal, lung, kidney, and endometrial cancers to assess safety and look for early signs of effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gabrail Cancer & Research Center

    RECRUITING

    Canton, Ohio, 44718, United States

    Contact

  • Grand Hopital de Charleroi (GHdC) - Hopital Notre Dame

    RECRUITING

    Charleroi, Belgium

    Contact

  • Henry Ford Cancer Institute

    RECRUITING

    Detroit, Michigan, 48202, United States

    Contact

  • Hosp 12 de Octubre

    RECRUITING

    Madrid, Spain

    Contact

  • Hospital General Universitario Gergorio Maranon

    RECRUITING

    Madrid, Spain

    Contact

  • Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22205, United States

    Contact

  • Washington University Medical Campus

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

Conditions

Explore the condition pages connected to this study.